McCarthy Asset Management’s China-Biotics, Inc. Common Stock CHBT Stock Holding History

McCarthy Asset Management’s Portfolio CHBT Stock Details CHBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-360	Closed	–	–	403
2021 Q2	$0	Hold	360	–	–	﹤0.01%	449
2021 Q1	$0	Hold	360	–	–	﹤0.01%	429
2020 Q4	$0	Buy	+360	New	–	﹤0.01%	383

McCarthy Asset Management's CHBT Position: Q3 2021 in Review

McCarthy Asset Management sold out of China-Biotics, Inc. Common Stock (CHBT) in Q3 2021, closing a stake of 360 shares.

McCarthy Asset Management first reported a position in CHBT in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold CHBT as of Q3 2021.

McCarthy Asset Management reported no remaining China-Biotics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
McCarthy Asset Management sold 360 China-Biotics, Inc. Common Stock shares in Q3 2021.
McCarthy Asset Management first reported a position in China-Biotics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
McCarthy Asset Management's China-Biotics, Inc. Common Stock position peaked at $0 in Q2 2021.
0 funds tracked by Wall St. Rank held China-Biotics, Inc. Common Stock as of Q3 2021.

Based on McCarthy Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.